RANTES modulates the release of glutamate in human neocortex

Journal of Neuroscience

Volumn 28, Issue 47, 2008, Pages 12231-12240

  Musante, Veronica ^a   Longordo, Fabio ^b   Neri, Elisa ^a   Pedrazzi, Marco ^a   Kalfas, Fotios ^c   Severi, Paolo ^c   Raiteri, Maurizio ^a   Pittaluga, Anna ^a,d  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF BASEL   (Switzerland)

^c GALLIERA HOSPITAL   (Italy)

^d Section of Pharmacology and Toxicology   (Italy)

Author keywords

Basal glutamate release; Chemokine receptors; Cytokine; Evoked glutamate release; Human neocortex; Human RANTES

Indexed keywords

ADENYLATE CYCLASE; ASPARTIC ACID; CALCIUM ION; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5 ANTAGONIST; G PROTEIN COUPLED RECEPTOR; GLUTAMIC ACID; INOSITOL TRISPHOSPHATE; PERTUSSIS TOXIN; PROTEIN TYROSINE KINASE; RANTES;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CALCIUM MOBILIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; EXOCYTOSIS; FEMALE; HUMAN; HUMAN TISSUE; MALE; MOUSE; NEOCORTEX; NERVE ENDING; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SYNAPTOSOME;

ADULT; AGED; ANALYSIS OF VARIANCE; ANIMALS; ASPARTIC ACID; CALCIUM; CHEMOKINE CCL5; D-ASPARTIC ACID; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; GLUTAMIC ACID; HUMANS; MACROCYCLIC COMPOUNDS; MALE; MICE; MIDDLE AGED; NEOCORTEX; OXAZOLES; RECEPTORS, CCR; SYNAPTOSOMES; TIME FACTORS; TRITIUM; YOUNG ADULT;

EID: 58149400025     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3212-08.2008     Document Type: Article

References (55)

1. Alvarez Losada S, Cantó-Nogués C, Muñoz- Fernández MA (2002) A new possible mechanism of human immunodeficiency virus type 1 infection of neural cells. Neurobiol Dis 11:469-478.
2. Amella CA, Sherry B, Shepp DH, Schmidtmayerova H (2005) Macrophage inflammatory protein 1alpha inhibits postentry steps of human immunodeficiency virus type 1 infection via suppression of intracellular cyclic AMP. J Virol 79:5625-5631.
3. Baggiolini M, Dewald B, Moser B (1994) Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol 55:97-179.
4. Bajetto A, Bonavia R, Barbero S, Schettini G (2002) Characterization of chemokines and their receptors in the central nervous system: physiopathological implications. J Neurochem 82:1311-1329.
5. Besong G, Battaglia G, D'Onofrio M, Di Marco R, Ngomba RT, Storto M, Castiglione M, Mangano K, Busceti CL, Nicoletti FR, Bacon K, Tusche M, Valenti O, Conn PJ, Bruno V, Nicoletti F (2002) Activation of group III metabotropic glutamate receptors inhibits the production of RANTES in glial cell cultures. J Neurosci 22:5403-5411.
6. Blanpain C, Vanderwinden JM, Cihak J, Wittamer V, Le Poul E, Issafras H, Stangassinger M, Vassart G, Marullo S, Schlndorff D, Parmentier M, Mack M (2002) Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies. Mol Biol Cell 13:723-737.
7. Bolin LM, Murray R, Lukacs NW, Strieter RM, Kunkel SL, Schall TJ, Bacon KB (1998) Primary sensory neurons migrate in response to the chemokine RANTES. J Neuroimmunol 81:49-57.
8. Boutet A, Salim H, Leclerc P, Tardieu M (2001) Cellular expression of functional chemokine receptor CCR5 and CXCR4 in human embryonic neurons. Neurosci Lett 311:105-108.
9. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
10. Cartier L, Hartley O, Dubois-Dauphin M, Krause KH (2005) Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res Brain Res Rev 48:16-42.
11. Cho C, Miller RJ (2002) Chemokine receptors and neural function. J Neurovirol 8:573-584.
12. Dunkley PR, Jarvie PE, Heath JW, Kidd GJ, Rostas JA (1986) A rapid method for isolation of synaptosomes on Percoll gradients. Brain Res 372:115-129.
13. El-Asmar L, Springael JY, Ballet S, Andrieu EU, Vassart G, Parmentier M (2005) Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers. Mol Pharmacol 67:460-469.
14. Elsner J, Petering H, Kimmig D, Wells TN, Proudfoot AE, Kapp A (1999) The CC chemokine receptor antagonist met-RANTES inhibits eosinophil effector functions. Int Arch Allergy Immunol 118:462-465.
15. Gafni J, Munsch JA, Lam TH, Catlin MC, Costa LG, Molinski TF, Pessah IN (1997) Xestospongins: potent membrane permeable blockers of the inositol 1,4,5-trisphosphate receptor. Neuron 19:723-733.
16. Ganor Y, Besser M, Ben-Zakay N, Unger T, Levite M (2003) Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migration. J Immunol 170:4362-4372.
17. Gillard SE, Lu M, Mastracci RM, Miller RJ (2002) Expression of functional chemokine receptors by rat cerebellar neurons. J Neuroimmunol 124:16-28.
18. Grilli M, Raiteri L, Pittaluga A (2004) Somatostatin inhibits glutamate release from mouse cerebrocortical nerve endings through presynaptic sst2 receptors linked to the adenylyl cyclase-protein kinase A pathway. Neuropharmacology 46:388-396.
19. Heath H, Qin S, Rao P, Wu L, LaRosa G, Kassam N, Ponath PD, Mackay CR (1997) Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J Clin Invest 99:178-184.
20. Hegg CC, Hu S, Peterson PK, Thayer SA (2000) Beta-chemokines and human immunodeficiency virus type-1 proteins evoke intracellular calcium increases in human microglia. Neuroscience 98:191-199.
21. Iarlori C, Reale M, Lugaresi A, De Luca G, Bonanni L, Di Iorio A, Feliciani C, Conti P, Gambi D (2000) RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-beta-1b. J Neuroimmunol 107:100-107.
22. 2+ mobilization and inositol trisphosphate (IP3) formation in cells transfected with G protein-coupled receptor 75. Br J Pharmacol 149:490-497.
23. Karpus WJ, Ransohoff RM (1998) Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis. J Immunol 161:2667-2671.
24. Kaul M, Lipton SA (1999) Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc Natl Acad Sci U S A 96:8212-8216.
25. Kaul M, Ma Q, Medders KE, Desai MK, Lipton SA (2007) HIV-1 coreceptors CCR5 and CXCR4 both mediate neuronal cell death but CCR5 paradoxically can also contribute to protection. Cell Death Differ 14:296-305.
26. Kelder W, McArthur JC, Nance-Sproson T, McClernon D, Griffin DE (1998) Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann Neurol 44:831-835.
27. Klein RS, Williams KC, Alvarez-Hernandez X, Westmoreland S, Force T, Lackner AA, Luster AD (1999) Chemokine receptor expression and signaling in macaque and human fetal neurons and astrocytes: implications for the neuropathogenesis of AIDS. J Immunol 163:1636-1646.
28. Kolb SA, Sporer B, Lahrtz F, Koedel U, Pfister HW, Fontana A (1999) Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon-gamma inducible protein 10. J Neuroimmunol 93:172-181.
29. Levi G, Raiteri M (1993) Carrier-mediated release of neurotransmitters. Trends Neurosci 16:415-419.
30. Longordo F, Feligioni M, Chiaramonte G, Sbaffi PF, Raiteri M, Pittaluga A (2006) The human immunodeficiency virus-1 protein transactivator of transcription up-regulates N-methyl-D-aspartate receptor function by acting at metabotropic glutamate receptor 1 receptors coexisting on human and rat brain noradrenergic neurones. J Pharmacol Exp Ther 317:1097-1105.
31. McManus CM, Weidenheim K, Woodman SE, Nunez J, Hesselgesser J, Nath A, Berman JW (2000) Chemokine and chemokine-receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulation. Am J Pathol 156:1441-1453.
32. Mellado M, Rodríguez-Frade JM, Vila-Coro AJ, Fernández S, Martín de Ana A, Jones DR, Torán JL, Martínez-A C (2001) Chemokine receptor homo-or heterodimerization activates distinct signaling pathways. EMBO J 20:2497-2507.
33. Meucci O, Fatatis A, Simen AA, Bushell TJ, Gray PW, Miller RJ (1998) Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc Natl Acad Sci U S A 95:14500-14505.
34. Millán C, Torres M, Sánchez-Prieto J (2003) Co-activation of PKA and PKC in cerebrocortical nerve terminals synergistically facilitates glutamate release. J Neurochem 87:1101-1111.
35. Mueller A, Mahmoud NG, Goedecke MC, McKeating JA, Strange PG (2002) Pharmacological characterization of the chemokine receptor, CCR5. Br J Pharmacol 135:1033-1043.
36. Myers SJ, Wong LM, Charo IF (1995) Signal transduction and ligand specificity of the human monocyte chemoattractant protein-1 receptor in transfected embryonic kidney cells. J Biol Chem 270:5786-5792.
37. Oh SB, Tran PB, Gillard SE, Hurley RW, Hammond DL, Miller RJ (2001) Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J Neurosci 21:5027-5035.
38. Oh SB, Endoh T, Simen AA, Ren D, Miller RJ (2002) Regulation of calcium currents by chemokines and their receptors. J Neuroimmunol 123:66-75.
39. Proudfoot AE, Buser R, Borlat F, Alouani S, Soler D, Offord RE, Schröder JM, Power CA, Wells TN (1999) Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptors. J Biol Chem 274:32478-32485.
40. Raiteri L, Raiteri M (2000) Synaptosomes still viable after 25 years of superfusion Neurochem Res 25:1265-1274.
41. Raiteri M (2006) Functional pharmacology in human brain. Pharmacol Rev 58:162-193.
42. Raiteri M, Sala R, Fassio A, Rossetto O, Bonanno G (2000) Entrapping of impermeant probes of different size into nonpermeabilized synaptosomes as a method to study presynaptic mechanisms. J Neurochem 74:423-431.
43. Ransohoff RM, Hamilton TA, Tani M, Stoler MH, Shick HE, Major JA, Estes ML, Thomas DM, Tuohy VK (1993) Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J 7:592-600.
44. 3H]D-aspartate release from rat frontal cortex in vitro. Neuropharmacology 49:59-72.
45. Sarchielli P, Di Filippo M, Candeliere A, Chiasserini D, Mattioni A, Tenaglia S, Bonucci M, Calabresi P (2007) Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP-and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients. J Neuroimmunol 188:146-158.
46. Sørensen TL, Tani M, Jensen J, Pierce V, Lucchinetti C, Folcik VA, Qin S, Rottman J, Sellebjerg F, Strieter RM, Frederiksen JL, Ransohoff RM (1999) Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest 103:807-815.
47. Springael JY, Urizar E, Parmentier M (2005) Dimerization of chemokine receptors and its functional consequences. Cytokine Growth Factor Rev 16:611-623.
48. Thellung S, Corsaro A, Villa V, Venezia V, Nizzari M, Bisaglia M, Russo C, Schettini G, Aceto A, Florio T (2007) Amino-terminally truncated prion protein PrP90-231 induces microglial activation in vitro. Ann N Y Acad Sci 1096:258-270.
49. Ubogu EE, Cossoy MB, Ransohoff RM (2006) The expression and function of chemokines involved in CNS inflammation. Trends Pharmacol Sci 27:48-55.
50. van der Meer P, Ulrich AM, Gonźalez-Scarano F, Lavi E (2000) Immunohistochemical analysis of CCR2, CCR3, CCR5, and CXCR4 in the human brain: potential mechanisms for HIV dementia. Exp Mol Pathol 69:192-201.
51. Wang SJ, Sihra TS (2003) Opposing facilitatory and inhibitory modulation of glutamate release elicited by cAMP production in cerebrocortical nerve terminals (synaptosomes). Neuropharmacology 44:686-697.
52. Wang SJ, Wang KY, Wang WC, Sihra TS (2006) Unexpected inhibitory regulation of glutamate release from rat cerebrocortical nerve terminals by presynaptic 5-hydroxytryptamine-2A receptors. J Neurosci Res 84:1528-1542.
53. Watson C, Jenkinson S, Kazmierski W, Kenakin T (2005) The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor. Mol Pharmacol 67:1268-1282.
54. Wells TN, Power CA, Shaw JP, Proudfoot AE (2006) Chemokine blockers-therapeutics in the making? Trends Pharmacol Sci 27:41-47.
55. Zhao J, Ma L, Wu YL, Wang P, Hu W, Pei G (1998) Chemokine receptor CCR5 functionally couples to inhibitory G proteins and undergoes desensitization. J Cell Biochem 71:36-45.